Pathwai is BranchLab's AI platform for privacy-first pharma commercialization.

BranchLab
BranchLab is a healthcare AI platform helping pharma companies commercialize therapies with privacy-safe data.
- Company
- New York, NY, USUnited States
BranchLab's Pathwai product is a unified AI platform for pharma commercialization, designed to predict health outcomes without PHI. Healthcare commercialization has long been constrained by strict regulatory requirements, fragmented data systems, and manual workflows.
BranchLab's deep learning models analyze longitudinal data to identify pathways predictive of specific health outcomes. BranchLab serves pharmaceutical manufacturers with one platform for research, marketing, and measurement.
Products & Services
Similar Companies

Prognos Health
prognoshealth.com

OptimizeRx
optimizerx.com

Propel Media
propelmedia.com

Swoop
swoop.com

Latent
latenthealth.com

OmicsBank
omicsbank.com

Humigent
humigent.ai

Trellis
runtrellis.com

Convexia
convexia.bio

Forus
forus.com

Enjamb Labs
enjamb.ai

ClosedLoop.ai
closedloop.ai

Medeloop
medeloop.ai

Rightview
rightview.ai

BioStack Platforms
getbiostack.com

Secure AI Labs
secureailabs.com

Theora
theorahq.com

Synthio Labs
synthiolabs.com

Bayesian Health
bayesianhealth.com

Optura
optura.ai
Quick Facts
Who are BranchLab's competitors?
Companies similar to BranchLab include Prognos Health, OptimizeRx, Propel Media and Swoop.
When was BranchLab founded?
BranchLab was founded in 2024.
Where is BranchLab's headquarters located?
BranchLab's headquarters is located in New York, NY, US.
When was BranchLab's last funding round?
BranchLab's most recent funding round was for $26M (USD) in May 2026.
How much disclosed funding has BranchLab raised?
As of May 13, 2026, BranchLab has disclosed funding of $26M (USD). Undisclosed round amounts are excluded.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Tags
- Headquarters
- 54 W 21st Street, Suite 404
- New York, NY, 10010
- US
- SEC CIK
- 0002017708
- EIN
- 99-1164807